EFFICACY, SAFETY AND TOLERABILITY OF ONCE-DAILY TIOTROPIUM RESPIMAT® ADD-ON THERAPY IN CHILDREN WITH MODERATE SYMPTOMATIC ASTHMA

被引：0

作者：

Schmidt, O. ^{[1
]}

Hamelmann, E. ^{[2
,3
]}

Vogelberg, C. ^{[4
]}

Laki, I. ^{[5
]}

El Azzi, G. ^{[6
]}

Engel, M. ^{[6
]}

Moroni-Zentgraf, P. ^{[6
]}

Finnigan, H. ^{[7
]}

Vandewalker, M. ^{[8
]}

机构：

[1] KPPK GmH, Koblenz, Germany

[2] Evangel Krankenhaus Bielefeld, Bochum, Germany

[3] Ruhr Univ, Allergy Ctr, Bochum, Germany

[4] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dresden, Germany

[5] Dept Paediat Pulmonol, Torokbalint, Hungary

[6] Boehringer Ingelheim Pharma GmbH & Co KG, TA Resp Dis, Ingelheim, Germany

[7] Boehringer Ingelheim Ltd, Biostat & Data Sci, Bracknell, Berks, England

[8] Ozarks Inc, Clin Res, Columbia, MO USA

来源：

THORAX | 2016年 / 71卷

关键词：

D O I：

10.1136/thoraxjnl-2016-209333.299

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

P156

引用

页码：A167 / A168

页数：6

共 50 条

[1] EFFICACY, SAFETY AND TOLERABILITY OF ONCE-DAILY TIOTROPIUM RESPIMAT® ADD-ON THERAPY IN CHILDREN WITH MODERATE SYMPTOMATIC ASTHMA
不详
THORAX, 2016, 71 : A272 - A272
[2] SAFETY AND TOLERABILITY OF ONCE-DAILY TIOTROPIUM RESPIMAT® ADD-ON THERAPY IN CHILDREN WITH SEVERE SYMPTOMATIC ASTHMA
Hamelmann, E.
Rupp, N.
Boner, A.
El Azzi, G.
Moroni-Zentgraf, P.
Engel, M.
Szefler, S. J.
PEDIATRIC PULMONOLOGY, 2016, 51 : S61 - S62
[3] Safety And Tolerability Of Once-Daily Tiotropium Respimat® Add-On Therapy In Children With Severe Symptomatic Asthma
Szefler, S. J.
Rupp, N.
Boner, A.
El Azzi, G.
Moroni-Zentgraf, P.
Engel, M.
Hamelmann, E.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
[4] LATE-BREAKING ABSTRACT: Safety and tolerability of once-daily tiotropium Respimat® add-on therapy in children with moderate symptomatic asthma
Vogelberg, Christian
Laki, Istvan
Schmidt, Olaf
Hamelmann, Eckard
El Azzi, Georges
Engel, Michael
Moroni-Zentgraf, Petra
Finnigan, Helen
Vandewalker, Mark
EUROPEAN RESPIRATORY JOURNAL, 2016, 48
[5] Safety and tolerability of once-daily tiotropium Respimat® add-on to at least inhaled corticosteroid maintenance therapy in adolescent patients with moderate or severe symptomatic asthma
Dahl, R.
Szefler, S. J.
Bernstein, J.
Vandewalker, M.
Engel, M.
Moroni-Zentgraf, P.
Unseld, A.
Hamelmann, E.
ALLERGY, 2015, 70 : 34 - 35
[6] Once-daily Tiotropium Respimat® Add-on Therapy Improves Lung Function and Control in Adolescents and Children with Moderate Symptomatic Asthma
Vogelberg, Christian
Hamelmann, Eckard
Szefler, Stanley J.
El Azzi, Georges
Moroni-Zentgraf, Petra
Engel, Michael
Sigmund, Ralf
Vandewalker, Mark L.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : AB95 - AB95
[7] Once-Daily Tiotropium Respimat® Add-On Therapy Improves Lung Function In Children With Severe Symptomatic Asthma
Szefler, S. J.
Harper, T.
Laki, I.
Boner, A.
El Azzi, G.
Moroni-Zentgraf, P.
Engel, M.
Hayman, A.
Hamelmann, E.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
[8] EFFICACY AND SAFETY ASSESSMENT OF ONCE-DAILY TIOTROPIUM RESPIMAT® ADD-ON TO INHALED CORTICOSTEROIDS IN ADOLESCENT PATIENTS WITH SYMPTOMATIC ASTHMA
Hamelmann, E.
Boner, A.
Bernstein, J.
Moroni-Zentgraf, P.
Engel, M.
Avis, M.
Unseld, A.
Vandewalker
PEDIATRIC PULMONOLOGY, 2015, 50 : S55 - S55
[9] ONCE-DAILY TIOTROPIUM RESPIMAT® ADD-ON TO MAINTENANCE THERAPY IN ADOLESCENT PATIENTS WITH SYMPTOMATIC ASTHMA: POOLED SAFETY ANALYSIS
Mansfield, L.
Harper, T., III
Moroni-Zentgraf, P.
Engel, M.
Luehmann, R.
Bernstein, J. A.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2015, 115 (05) : A55 - A55
[10] Once-daily tiotropium Respimat add-on therapy improves lung function in children with moderate symptomatic asthma, independent of the degree of airflow obstruction
Vogelberg, Christian
Halpin, David
Voelker, Birgit
Engel, Michael
Luehmann, Reinhold
Hamelmann, Eckard
EUROPEAN RESPIRATORY JOURNAL, 2017, 50

← 1 2 3 4 5 →